Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Amicus Therapeutics (FOLD) Insider Trading & Ownership

Amicus Therapeutics logo

Amicus Therapeutics (NASDAQ:FOLD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$5.05M
Get FOLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Amicus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FOLD Insider Buying and Selling by Quarter

Amicus Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/2/2026Sell22,500$14.35$322,875.00  
1/20/2026Sell75,000$14.31$1,073,250.00  
12/19/2025Sell25,642$14.17$363,347.14  
12/15/2025Sell77,926$10.86$846,276.36  
12/15/2025Sell25,643$11.00$282,073.00  
12/1/2025Sell14,587$10.01$146,015.87  
11/26/2025Sell23,621$10.00$236,210.00  
11/25/2025Sell36,000$10.00$360,000.00  
11/24/2025Sell14,587$10.04$146,453.48  
11/24/2025Sell25,643$10.10$258,994.30  
11/24/2025Sell76,158$10.16$773,765.28  
11/4/2025Sell25,643$9.51$243,864.93  
(Data available from 1/1/2013 forward)

FOLD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Amicus Therapeutics includes Bradley L Campbell, David Michael Clark, Ellen Rosenberg, Jeff Castelli, John F Crowley, Margaret G Mcglynn, and Samantha Prout. Learn more on insiders at FOLD.

2.20% of Amicus Therapeutics stock is owned by insiders. Learn more on FOLD's insider holdings.

The following insiders have sold FOLD shares in the last 24 months: Bradley L Campbell ($3,104,608.21), David Michael Clark ($1,148,279.37), Ellen Rosenberg ($596,210.00), and Jeff Castelli ($773,765.28).

Insiders have sold a total of 494,851 Amicus Therapeutics shares in the last 24 months for a total of $5,622,862.86 sold.



This page (NASDAQ:FOLD) was last updated on 5/11/2026 by MarketBeat.com Staff.
From Our Partners